Quick-Med Technologies, Inc. Receives Wound Healing Society's Prestigious Blue Ribbon Award

NIMBUST in focus at this year's Wound Healing Society Annual Meeting

Gainesville, Florida – May 31, 2006 – Quick-Med Technologies, Inc. (OTC Bulletin Board: QMDT) (“Quick-Med Technologies” or “QMT”) is pleased to announce that Bernd Liesenfeld, Ph.D., senior scientist at QMT, received the Blue Ribbon Award at the Wound Healing Society’s 16th Annual Meeting for the outstanding abstract entitled: “A Novel Moist Wound Healing Dressing that Provides Sustained Antimicrobial Activity and Protease Inhibition to Speed Healing”. The abstract was sponsored by Quick-Med Technologies and the University of Florida at Gainesville.

The Wound Healing Society offers the Blue Ribbon Industrial Research & Development Award in recognition of research showing the mechanisms of action or efficacy for advanced new products. This competition was designed to provide recognition for the best product-oriented research performed by research and development scientists within the corporate world.  Other participants at the event were prominent companies such as Johnson & Johnson Wound Management, Convatec Wound Therapeutics™, and Healthpoint, Ltd., as well as the Harvard Medical School.

 “This is a significant recognition by the thought leaders in the field of wound healing. The combination of a novel microbiocidal coating and a soluble metalloprotease inhibitor has the potential to be an important advance in wound dressings for both military and civilian applications.” stated Professor Gregory S. Schultz Ph.D., Vice President of Clinical Research & Development of Quick-Med Technologies and a Professor of Obstetrics and Gynecology at the University of Florida.

The abstract represents work done in conjunction with a Small Business Innovative Research (SBIR) Phase I award from the U.S. Army Medical Research and Material Command granted to Quick-Med Technologies (1)(2), specifically to promote healing of vesicant (i.e. chemical blister agent burns) injuries. The novel dressing consists of a superabsorbent substrate treated with a non-leachable polycationic biocide coupled with a diffusible protease inhibitor/antibiotic. The dressing has commercial applications to a wide variety of acute and chronic wounds. The abstract poster in its entirety can be accessed by clicking here.

“Our team is greatly honored by this recognition from such a prestigious body as the Wound Healing Society.” stated Dr. Liesenfeld, Senior Polymer Chemist of Quick-Med Technologies. “It’s exciting to work on projects where the goal is so rewarding in both a scientific and social sense.” added Dr. Liesenfeld.

Source:

1. Quick-Med Technologies, Inc. Awarded U.S. Army SBIR Phase I Contract – November 15, 2005 Press Release
2. This work is supported by the U.S. Army Medical Research and Material Command under Contract No. W81XWH-06-C-0024.

About the Wound Healing Society

The Wound Healing Society is a non-profit organization composed of clinical and basic scientists. The Society provides a forum for interaction among scientists, physicians, licensed practitioners, industrial representatives and government agencies. Founded in 1990, the Society is recognized among professionals and government agencies as the leading scientific organization focused in this area of wound healing. The Society publishes the leading journal in this area, Wound Repair and Regeneration.

About Quick-Med Technologies, Inc.
Quick-Med Technologies is a life sciences company focused in developing proprietary, broad-based technologies for consumer, industrial, and healthcare use, as well as for advanced military and civilian medical applications. The Company¹s two core products under development are (1) MultiStat™, a family of advanced compounds shown to be effective in broad-based skin therapy applications, and (2) NIMBUS™, a family of advanced polymers that can be used in a wide range of applications from advanced wound care to wood preservatives. Quick-Med Technologies is listed under the symbol "QMDT" on the OTC Bulletin Board. For additional information, visit Quick-Med Technologies¹ website: www.quickmedtech.com or email: info@quickmed-technologies.com

For additional further information, please contact QMT:

David S. Lerner -- President
Phone : (561) 750-4202
Email: dlerner@quickmed-technologies.com

Natasha A. Sorobey -- Corporate & Investor Relations (Canada)
Phone: (403) 203-4748
Email: nsorobey@quickmed-technologies.com

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including launch and approval of the potential products described herein and the Company¹s results of operations. The Company is also subject to other risks as detailed from time-to-time in the Company¹s SEC filings.